DrFARM:在全基因组关联研究中识别类基因变异
Lap Sum Chan1, Gen Li1, Eric B Fauman2
1Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Nature communications
|July 2, 2025
概括
一种新的统计方法,即偏差规范化因子分析回归模型 (DrFARM),改善了类基因变异的识别. 这种方法可以更好地控制虚假发现,并成功识别了与代谢物相关的新基因.
科学领域:
- 遗传学 是一个遗传学.
- 统计遗传学 统计遗传学
- 生物信息学是一种生物信息学.
背景情况:
- 识别类变异的标准方法依赖于单独的全基因组关联研究 (GWAS),由于边际总结统计数据可能产生虚假结果.
- 高维基遗传数据中的多层依赖性对准确的变异分析构成挑战.
研究的目的:
- 引入一种新的统计方法,即偏差规范化因子分析回归模型 (DrFARM),用于同时分析遗传变异和多级依赖.
- 为了加强对整体错误率的控制,并使普世错误发现率 (FDR) 控制在类变体识别.
主要方法:
- DrFARM采用联合回归模型,用于同时分析高维基遗传变异.
- 该方法整合了 debiasing 技术和 Cauchy 组合测试,用于理论上合理的选择后推断.
- 这种方法确保了对整体虚假发现率 (FDR) 的稳健控制.
主要成果:
- 广泛的模拟表明,DrFARM有效地控制了整体的FDR.
- 适用于男性代谢综合征 (METSIM) 研究数据确定了1031个测量代谢物的五个新型假定因果基因.
- 这些确定的基因以前没有涉及任何代谢物GWAS,包括先前对METSIM队列的分析.
结论:
- DrFARM提供了一种统计学上严格且有效的方法来识别类变异.
- 该方法克服了标准方法的局限性,在遗传关联研究中提供了更高的准确性.
- 这种方法有可能提高我们对复杂特征和疾病遗传基础的理解.
相关概念视频
Pleiotropy
31.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.2K
Comparing Copy Number Variations and SNPs
11.6K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
11.6K
Single Nucleotide Polymorphisms-SNPs
14.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K
Principles of Pharmacogenetics: Types of Genetic Variants
137
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
137
Pharmacogenomics: Identification of New Drug Targets
120
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
120


